Home » Headline, NHS Research News

New Research Institute for Early Stage Drug Trials

No Comment

A brand new institute – The Translational (early stage) Research Partnerships – has been created by the government to cut red tape and allow various different institutions to combine forces to discover ground-breaking new drug treatments.

The idea is to allow both public and private groups to work together, so speeding up the process from trials to full patient use.  The whole procedure will be overseen by the National Institute for Health Research (NIHR).

This new funding will mean that the NHS, life science companies and university clinical researchers will be able to focus primarily on working towards drugs to treat conditions such as asthma and arthritis.  It will also provide the ability for life science companies to discuss early stage breakthroughs with some of the leading names in medical science.

This exciting collaboration is hoped to make the UK a much more tempting prospect for pharmaceutical companies to invest.  It will cut red tape and allow them to sign a single contract with the NIHR, rather than multi-negotiations with different parties.

The government, who have provided £1.3 million towards the new project, are very keen to not only attract the pharmaceutical companies to Britain, but to ‘create the right environment for the life science industries.’  They believe that this industry is a key component to encourage economic growth.

Initial reactions from all parties involved has been very positive, with the various institutions and leading names in the industry providing a straightforward collaboration in order to allow the new research industry to be set up.

Share and Enjoy:
  • Print
  • Digg
  • StumbleUpon
  • del.icio.us
  • Facebook
  • Yahoo! Buzz
  • Twitter
  • Google Bookmarks
  • LinkedIn